Patient Education & Adherence Flashcards

Which patient group is most likely to benefit from a pill organizer or blister pack to improve statin adherence?

Answer: Elderly patients on multiple medications with complex regimens

Elderly patients on polypharmacy benefit most from organizational aids like pill organizers to reduce missed doses.

A patient states they stopped their statin because they read online it 'causes diabetes.' What should the clinician emphasize?

Answer: Statins carry a small increased risk of diabetes (~10%), but cardiovascular benefits far outweigh this risk in high-risk patients

Statins modestly increase diabetes risk (~10%), but for high cardiovascular risk patients, the ASCVD event reduction clearly outweighs this risk.

Which of the following is a validated tool used to assess medication adherence in lipid management clinical practice?

Answer: Morisky Medication Adherence Scale (MMAS)

The Morisky Medication Adherence Scale (MMAS) is a widely validated self-report tool used to identify adherence barriers.

A patient with high triglycerides (800 mg/dL) is being counseled on dietary fat restriction. What is the recommended fat intake target?

Answer: Less than 10-15% of total calories from fat

For severe hypertriglyceridemia, dietary fat is restricted to 10-15% of total calories to minimize chylomicron formation.

Which behavioral strategy is most effective at sustaining long-term lipid medication adherence according to adherence literature?

Answer: Simplifying regimens, using reminders, and addressing patient-specific barriers collaboratively

Simplification, reminder systems, and collaborative problem-solving are the most evidence-supported strategies for sustained adherence.

When educating a patient about omega-3 fatty acids (icosapentaenoic acid) for cardiovascular risk reduction, which statement is most accurate?

Answer: Prescription-strength EPA (icosapentaenoic acid) at 4g/day reduces cardiovascular events in high-risk patients

Prescription icosapentaenoic acid (Vascepa) at 4g/day demonstrated ASCVD event reduction in the REDUCE-IT trial.

A patient on rosuvastatin asks whether it is safe to take their pill in the morning instead of evening. What is the best response?

Answer: Rosuvastatin has a long half-life and can be taken at any time of day consistently

Rosuvastatin's long half-life (~19 hours) allows flexible dosing at any consistent time of day.